Lack of Discernible Benefit of High-Dose Aspirin in the Treatment of Kawasaki Disease

Journal of the Pediatric Infectious Diseases Society 2026

View at publisher
Authors: Lavina Thadani, Huthaifah Khan, Kwang‐Youn A. Kim, Shulman St, Anne Rowley
DOI: 10.1093/jpids/piag002
Cited by: 1
References: 17

Abstract

In a retrospective single-center cohort study of 460 children with Kawasaki Disease, initial treatment with low-dose aspirin and intravenous immunoglobulin (IVIG) resulted in similar coronary artery outcomes and IVIG retreatment rates compared to high-dose aspirin and IVIG. These findings support consideration of low-dose aspirin for the management of acute-phase Kawasaki Disease.

Fields of Study & Subjects

Kawasaki Disease and Coronary Complications Platelet Disorders and Treatments Blood Coagulation and Thrombosis Mechanisms

Publication details

Journal / source
Journal of the Pediatric Infectious Diseases Society
Publisher
Oxford University Press (OUP)
Volume
15
Issue
2
Publication date
13 January 2026
Language
EN